Financial Gravity Asset Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1
Closed -$117 1196
2023
Q4
$117 Buy
+1
New +$93 ﹤0.01% 1085
2021
Q3
$149K Hold
1
0.07% 248
2021
Q2
$245K Buy
+1
New +$262 0.09% 145
2020
Q4
$3K Buy
+9
New +$2.31K ﹤0.01% 251
2019
Q4
$167K Sell
3
-142
-98% -$21.1K 0.12% 153
2019
Q3
$19K Buy
145
+58
+67% +$7.55K 0.02% 460
2019
Q2
$11K Buy
87
+83
+2,075% +$9.85K 0.01% 572
2019
Q1
$1K Buy
+4
New +$502 ﹤0.01% 1028
2018
Q3
$2K Sell
15
-441
-97% -$48.7K ﹤0.01% 921
2018
Q2
$52K Buy
456
+422
+1,241% +$31K 0.05% 309
2018
Q1
$2K Buy
+34
New +$1.94K ﹤0.01% 921

Other funds holding AMED

Financial Gravity Asset Management's AMED Position: Q1 2024 in Review

Financial Gravity Asset Management sold out of Amedisys (AMED) in Q1 2024, closing a stake of 1 share — an estimated $117 sold.

Financial Gravity Asset Management first reported a position in AMED in Q1 2018 and held it in 11 quarters. The position peaked at $245K in Q2 2021. 283 funds tracked by Wall St. Rank hold AMED as of Q1 2024.

  • Financial Gravity Asset Management reported no remaining Amedisys position as of Q1 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 1 Amedisys share in Q1 2024, an estimated $117.
  • Financial Gravity Asset Management first reported a position in Amedisys in Q1 2018 and held it in 11 quarters.
  • Financial Gravity Asset Management's Amedisys position peaked at $245K in Q2 2021.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q1 2024.

Based on Financial Gravity Asset Management's 13F filing for Q1 2024, filed 13 May 2024.